Skip to main content
Pills Pills Pills Pills Pills Pills

Mirtazapine Recall & Mislabeled Medication Lawsuits

Thank you for considering The Lyon Firm. At this time, we are not accepting plaintiffs related to this specific consumer issue. However, if you would like to be contacted in the future, please complete the contact form. By completing the form you will be contacted if the Firm begins accepting new cases on this matter, and you will also be included in firm news alerts related to important consumer safety and privacy issues to help keep you informed about related issues.

Cincinnati, Ohio pharmaceutical recall attorney reviewing labeling errors, drug injury cases and the recent mirtazapine recall for plaintiffs nationwide

At least one lot of Mirtazapine has been recalled because the tablets in the released bottles could be twice as strong as the bottle’s labeling indicates. Mirtazapine is used as a clinical depression treatment and is produced by Aurobindo Pharma USA, Inc.

The Aurobindo FDA-posted recall says bottles from lot No. 03119002A3, with an expiration on 03/2022 are mislabeled. The labels say the 500-count bottles should have 7.5 mg tablets though may have 15 mg tablets. The medication is also sold under the brand name Remeron.

Taking higher doses of mirtazapine than expected may increase the risk of sedation, agitation, increased reflexes, tremor, sweating, dilated pupils, gastrointestinal distress, nausea, constipation and other adverse drug effects.

Safety officials are concerned that unexpected levels of sedation in particular can contribute to dangerous falls or risky operation of motor vehicle accidents. The mirtazapaine recall was announced by Aurobindo on December 30, and by the FDA on December 31, 2019.

Joe Lyon is a Cincinnati, Ohio drug recall lawyer reviewing cases of mislabeled medications and defective pharmaceuticals. If you have been affected by the mirtzapine recall and have legal questions, call for a free consultation.

Mirtazapine Recall

Mirtazapine is indicated for the treatment of major depressive disorder and are usually packaged in 500 count bottles. Aurobindo Pharma is notifying its distributors and is arranging for return of all of the recalled product. Consumers with medical questions regarding the mirtazapine recall or to report can contact Aurobindo Pharma USA, Inc. or a consumer protection attorney.

Drug companies have a duty to release safe products, and when they fail to protect consumers with basic product safety measures, such as mislabeling, the companies can be held liable when injuries occur.

Drug recalls are quite common, and are not isolated events. Each year, hundreds of medications are recalled for a variety of reasons that may include the following:

  • Mislabeled pharmaceuticals
  • Drug contamination
  • Incorrect dosage information
  • Deviations in potency
  • Manufacturing defects

If a loved one has suffered an injury due to a mislabeled medication, and you have questions about the legal remedies available to improve quality of life and medical care, contact The Lyon Firm at (800) 513-2403. You will speak directly with Mr. Lyon, a pharmaceutical recall lawyer, and he will help you answer critical questions.

Antidepressant Recall, Defective Labeling Lawsuit, Labeling Error, Mirtazapine Injury, Mirtazapine Lawsuit, Mislabeling Lawsuits

Leave a Reply